New imaging showdown: can MBI outperform DBT for dense breast cancer detection?

NCT ID NCT03220893

First seen Feb 03, 2026 · Last updated May 15, 2026 · Updated 17 times

Summary

This study compared two breast imaging methods—molecular breast imaging (MBI) and digital breast tomosynthesis (DBT)—in over 3,000 women with dense breast tissue. The goal was to see if MBI could find more invasive cancers than DBT alone. Dense breast tissue can make mammograms harder to read, so better screening tools may help catch cancer earlier.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Henry Ford Hospital

    Detroit, Michigan, 48202, United States

  • M D Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Mayo Clinic Health System-Franciscan Healthcare

    La Crosse, Wisconsin, 54601, United States

  • Mayo Clinic in Rochester

    Rochester, Minnesota, 55905, United States

  • Toledo Clinic Cancer Centers-Toledo

    Toledo, Ohio, 43623, United States

Conditions

Explore the condition pages connected to this study.